With $30 Million Series B In Hand, Elevation Prepares To Take Inhalable COPD Drug Up To Phase III
This article was originally published in The Pink Sheet Daily
Executive Summary
The two-tranche financing, backed 50% by new investor Novo Ventures, will enable the private firm to evaluate early partnering opportunities from a position of financial stability.